The association between plasma 25-hydroxyvitamin D and subgroups in age-related macular degeneration: a cross-sectional study.

The association between plasma 25-hydroxyvitamin D and subgroups in age-related macular degeneration: a cross-sectional study.

To evaluate potential differences in plasma 25-hydroxyvitamin in subtypes of age-related macular degeneration (AMD), and in patients in Clinical Age-Related Maculopathy Staging (CARMS) group 5 with or without subretinal fibrosis.This single-center cross-sectional study included 178 participants duri...

Full description

Bibliographic Details
Main Authors:	Amardeep Singh, Mads Krüger Falk, Yousif Subhi, Torben Lykke Sørensen
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2013-01-01
Series:	PLoS ONE
Online Access:	http://europepmc.org/articles/PMC3726594?pdf=render

Similar Items

Systemic frequencies of T helper 1 and T helper 17 cells in patients with age-related macular degeneration: A case-control study
by: Amardeep Singh, et al.
Published: (2017-04-01)

Complement factor H Y402H polymorphism results in diminishing CD4+ T cells and increasing C-reactive protein in plasma
by: Marie Krogh Nielsen, et al.
Published: (2023-11-01)

Systemic and Ocular Long Pentraxin 3 in Patients with Age-Related Macular Degeneration.
by: Helene Bæk Juel, et al.
Published: (2015-01-01)

Altered activation state of circulating neutrophils in patients with neovascular age-related macular degeneration
by: Marie Krogh Nielsen, et al.
Published: (2017-07-01)

Plasma 25-Hydroxyvitamin-D (25-OHD) levels and late-stage age-related macular degeneration (AMD): Assessing the correlation
by: Supanji Supanji, et al.
Published: (2022-12-01)

The transcriptome of peripheral blood mononuclear cells in patients with clinical subtypes of late age-related macular degeneration
by: Yousif Subhi, et al.
Published: (2019-08-01)

Foveal morphology affects self-perceived visual function and treatment response in neovascular age-related macular degeneration: a cohort study.
by: Yousif Subhi, et al.
Published: (2014-01-01)

CX3CL1/CX3CR1 and CCL2/CCR2 chemokine/chemokine receptor complex in patients with AMD.
by: Mads Krüger Falk, et al.
Published: (2014-01-01)

Correlation of macular sensitivity measures and visual acuity to vision-related quality of life in patients with age-related macular degeneration
by: Thomas Richard Johansen Forshaw, et al.
Published: (2021-03-01)

Serum 25-Hydroxyvitamin D Is Differentially Associated with Early and Late Age-Related Macular Degeneration in the United States Population
by: Yihang Fu, et al.
Published: (2023-02-01)

Patients with myeloproliferative neoplasms and high levels of systemic inflammation develop age-related macular degeneration
by: Charlotte Liisborg, et al.
Published: (2020-09-01)

Patient perspectives and barriers in the treatment of neovascular age-related macular degeneration in Denmark: a qualitative study
by: Jakob Grauslund, et al.
Published: (2023-11-01)

Visual Hallucinations in a Patient with Horner's Syndrome Secondary to Internal Carotid Dissection
by: Amardeep Singh, et al.
Published: (2014-10-01)

VEGF Inhibition Associates With Decreased Risk of Mortality in Patients With Neovascular Age-related Macular Degeneration
by: Benjamin Sommer Thinggaard, MD, et al.
Published: (2024-05-01)

Serum levels of IL-4, IL-13 and IL-33 in patients with age-related macular degeneration and myeloproliferative neoplasms
by: Kathrine Gotfredsen, et al.
Published: (2023-03-01)

In patients with neovascular age-related macular degeneration, physical activity may influence C-reactive protein levels
by: Subhi Y, et al.
Published: (2013-12-01)

Studies on the transport of vitamin D and of 25-hydroxyvitamin D in human plasma
by: K Kida, et al.
Published: (1976-09-01)

The association between neovascular age-related macular degeneration and regulatory T cells in peripheral blood
by: Madelung CF, et al.
Published: (2015-06-01)

Maternal plasma 25-hydroxyvitamin D concentrations and the risk for gestational diabetes mellitus.
by: Cuilin Zhang, et al.
Published: (2008-01-01)

The Importance of Dose, Frequency and Duration of Vitamin D Supplementation for Plasma 25-Hydroxyvitamin D
by: Ludovic Brunel, et al.
Published: (2013-10-01)

Macular and Plasma Xanthophylls Are Higher in Age-related Macular Degeneration than in Normal Aging
by: Gerald McGwin, Jr., PhD, et al.
Published: (2023-06-01)

25 Hydroxyvitamin D and Cytokines in Multiple Sclerosis
by: Slavov Georgi Sv., et al.
Published: (2015-12-01)

Integrative metabolome and lipidome analyses of plasma in neovascular macular degeneration
by: Tantai Zhao, et al.
Published: (2023-10-01)

Association between plasma 25-hydroxyvitamin D levels and fracture risk: the EPIC-Oxford study.
by: Roddam, A, et al.
Published: (2007)

Differences in Plasma 25-Hydroxyvitamin D Levels at Diagnosis of Celiac Disease and Type 1 Diabetes
by: Monica Marino, et al.
Published: (2024-03-01)

Plasma 25-hydroxyvitamin D2 and D3 levels and incidence of postoperative atrial fibrillation
by: G. V. Skuladottir, et al.
Published: (2016-01-01)

Clinical and serological association of plasma 25-hydroxyvitamin D (25(OH)D) levels in lupus and the short-term effects of oral vitamin D supplementation
by: Chengappa Kavadichanda, et al.
Published: (2023-01-01)

Splenic monocytes drive pathogenic subretinal inflammation in age-related macular degeneration
by: Christophe Roubeix, et al.
Published: (2024-01-01)

The serum level of 25-hydroxyvitamin D for maximal suppression of parathyroid hormone in children: the relationship between 25-hydroxyvitamin D and parathyroid hormone
by: Jung In Kang, et al.
Published: (2017-02-01)

Plasma Levels of Matrix Metalloprotease MMP-9 and Tissue Inhibitor TIMP-1 in Caucasian Patients with Polypoidal Choroidal Vasculopathy
by: Jakob Ø. Sørensen, et al.
Published: (2020-05-01)

Role of ranibizumab in management of macular degeneration
by: Singh Rishi, et al.
Published: (2007-01-01)

Determination of Serum 25-Hydroxyvitamin D Levels in Patients with Alopecia Areata
by: Manisha Singh Basukala, et al.
Published: (2023-03-01)

Analytical Performance Specifications for 25-Hydroxyvitamin D Examinations
by: Etienne Cavalier, et al.
Published: (2021-01-01)

Gender, Obesity, Fat Distribution and 25-Hydroxyvitamin D
by: Maria Teresa Guagnano, et al.
Published: (2023-06-01)

Plasma 25-hydroxyvitamin D concentration and lymphoma risk: results of the European Prospective Investigation into Cancer and Nutrition.
by: Łuczyńska, A, et al.
Published: (2013)

Optimisation and validation of ultrahigh performance liquid chromatography method for quantification of 25-hydroxyvitamin d in maternal plasma
by: Lee, Siew Siew, et al.
Published: (2020)

25-Hydroxyvitamin D is associated with plasma renin activity and the pressor response to dietary sodium intake in Caucasians
by: Anand Vaidya, et al.
Published: (2011-09-01)

Plasma 25-Hydroxyvitamin D and Severe Pre-Eclampsia in a Population With Profound Vitamin D Deficiency
by: Mahmood Soveid, et al.
Published: (2016-07-01)

Pre-diagnostic plasma 25-hydroxyvitamin D levels and risk of non-melanoma skin cancer in women.
by: Geyu Liang, et al.
Published: (2012-01-01)

Serum 25-hydroxyvitamin D is negatively associated with severe periodontitis: a cross-sectional study
by: Fangjing Zhou, et al.
Published: (2021-09-01)